Infectious Disease Alert Updates
Infectious Disease Alert
; 42(4):45261.0, 2023.
Article
in English
| CINAHL | ID: covidwho-2238073
ABSTRACT
The article discusses the retrospective cohort study performed at the Mayo Clinic in Minnesota from February to June 2022, the first peer-reviewed publication demonstrating the efficacy of the monoclonal antibody bebtelovimab in the prevention of severe COVID-19 infection compared with nirmatrelvir/ritonavir. It mentions that the Food and Drug Administration has issued emergency use authorizations for six new monoclonal antibodies in the fight against SARS-CoV-2.
Search on Google
Collection:
Databases of international organizations
Database:
CINAHL
Language:
English
Journal:
Infectious Disease Alert
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS